Skip to main content
Log in

Effects of BAYl 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: Comparison with standard dose nifedipine

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

116 patients from 4 clinics participated in a double blind study to assess the efficacy of (BAYl 5240), a nifedipine-acebutolol fixed combination (10 mg+100 mg), as compared to nifedipine 20 mg in essential hypertension. During the 10 week study, the mean recumbent blood pressure decreased 1 to 3 h after treatment from 175.5/105.2 to 148.3/88.0 mmHg in the BAY1 5240 group and from 174.3/102.9 to 150.3/86.5 mmHg in the nifedipine group. The results also showed a comparable decrease in the mean systolic (SBP) and diastolic (DBP) blood pressures before treatment (24 h after last tablet) and after physical exertion before and after either drug given for 4 weeks. Doubling of the dose for 4 additional weeks produced a moderate and similar additional decrease in blood pressure. The results show the possibility of treating essential hypertension with a low dose of a beta-adrenergic blocking agent in combination with 10 mg nifedipine. Both regimens were well tolerated. One patient in the BAYl 5240 group and 2 in the nifedipine group, all treated by the same investigator, were withdrawn from the study because of headache during the nifedipine pre-period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hallin L, Andren L, Hansson L (1983) Controlled trial of nifedipine and bendroflumethiazide in hypertension. J Cardiovasc Pharmacol 5: 1083–1085

    Article  PubMed  CAS  Google Scholar 

  2. Murphy MB, Scriven AJI, Dollery CT (1983) Role of nifedipine in treatment of hypertension. Br Med J 287: 257–259

    CAS  Google Scholar 

  3. Hornung RS, Gould BA, Jones RI, Sonecha TN, Raftery EB (1983) Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording. Am J Cardiol 51: 1323–1327

    Article  PubMed  CAS  Google Scholar 

  4. Cowling CGD (1981) Acebutolol: a review. Curr Ther Res 30: 765–774

    Google Scholar 

  5. Ogilvie RI, Hamet P, Kreeft JH, Larochelle P, Marquez-Julio A (1983) Once-daily dosing of acebutolol in hypertension. J Cardiovasc Pharmacol 5: 157–161

    Article  PubMed  CAS  Google Scholar 

  6. Turner AS, Brocklehurst JC (1983) Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension. Curr Med Res Opin 8 [8]: 570–576

    PubMed  CAS  Google Scholar 

  7. Harris L, Dargie HJ, Lynch PG, Bulpitt CJ, Krikler DM (1982) Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. Br Med J 284: 1148–1151

    Article  CAS  Google Scholar 

  8. Yagil Y, Kobrin I, Stessman J, Ghanem J, Leibel B, Ben-Ishay D (1983) Effectiveness of combined nifedipine and propranolol treatment in hypertension. Hypertension 5 [Suppl 2]: II-113–II-117

    CAS  Google Scholar 

  9. Corea L, Alunni G, Bentivoglio M, Boschetti E, Cosmi F, Giaimo MD, Miele N, Motolese M (1980) Acute and long-term effects of nifedipine on plasma renin activity and plasma catecholamines in controls and hypertensive patients before and after metoprolol. Acta Therap 6: 177–189

    CAS  Google Scholar 

  10. Ekelund LG, Ekelund C, Roessner S (1982) Antihypertensive effects at rest and during exercise of a calcium blocker, nifedipine, alone and in combination with metoprolol. Acta Med Scand 212: 71–75

    PubMed  CAS  Google Scholar 

  11. Dean S, Kendall MJ (1983) Nifedipine in the treatment of difficult hypertensives. Eur J Clin Pharmacol 24: 1–5

    Article  PubMed  CAS  Google Scholar 

  12. Strano A, Novo S, Licata G, Salerno L, Pinto A, Favi, Botinardi G (1982) Efectos de la asociacion nifedipina-acebutolol en el tratamiento de pacientes con hipertension arterial esencial. Rev Esp Cardiol 35: 13–18

    Google Scholar 

  13. Husted SE, Kraemmer Nielsen H, Christensen CK, Lederballe Pedersen O (1982) Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoreceptor blocking agent. Eur J Clin Pharmacol 22: 101–103

    Article  PubMed  CAS  Google Scholar 

  14. Hardin JM, Fournier A, Alexandre JM, Lombaert M, Ronco G, Bezoc JF, Desmet, Quichaud J (1976) Effect antihypertenseur et inhibition du systeme nerveux sympathique par l'acebutolol. J Urol Nephrol (Paris) 82: 792–798

    CAS  Google Scholar 

  15. Franz I-W (1982) Vergleichende ergometrische Untersuchungen über die Wirkung vonβ-Rezeptorenblockern-Rezeptorenblockern und Diuretika und deren Kombination auf den Blutdruck und das Doppelprodukt bei Hochdruckkranken. Z Kardiol 71: 129–137

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lejeune, P., Gunselmann, W., Hennies, L. et al. Effects of BAYl 5240, a fixed combination of low dose nifedipine and acebutolol on hypertension: Comparison with standard dose nifedipine. Eur J Clin Pharmacol 28, 17–21 (1985). https://doi.org/10.1007/BF00635702

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00635702

Key words

Navigation